Last reviewed · How we verify
Ropivacaine 0.2% Injectable Solution ESPB
Ropivacaine 0.2% Injectable Solution ESPB is a Small molecule drug developed by Poznan University of Medical Sciences. It is currently FDA-approved. Also known as: erector spinae plane block.
Ropivacaine 0.2% Injectable Solution is a small molecule used in various medical interventions, including Erector Spinae Plane Block and PENG block, for conditions such as spine disease, hip arthropathy, hip osteoarthritis, hip pain chronic, and knee arthritis. It has been studied in clinical trials for its analgesic efficacy in elderly patients undergoing lumbar spine surgery.
At a glance
| Generic name | Ropivacaine 0.2% Injectable Solution ESPB |
|---|---|
| Also known as | erector spinae plane block |
| Sponsor | Poznan University of Medical Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Erector Spinae Plane Block for Acute Low Back Pain (NA)
- PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty (PHASE4)
- Two-level ESPB in Total Knee Arthroplasty (PHASE4)
- Erector Spinae Plane Block Vs. IPACK Block with Adductor Canal Block for Total Knee Arthroplasty (PHASE4)
- Erector Spinae vs. PENG Block for Total Hip Arthroplasty (PHASE4)
- Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Spine Surgery (PHASE4)
- ESPB vs iPACK+ACB in Total Knee Arthroplasty (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ropivacaine 0.2% Injectable Solution ESPB CI brief — competitive landscape report
- Ropivacaine 0.2% Injectable Solution ESPB updates RSS · CI watch RSS
- Poznan University of Medical Sciences portfolio CI
Frequently asked questions about Ropivacaine 0.2% Injectable Solution ESPB
What is Ropivacaine 0.2% Injectable Solution ESPB?
Who makes Ropivacaine 0.2% Injectable Solution ESPB?
Is Ropivacaine 0.2% Injectable Solution ESPB also known as anything else?
What development phase is Ropivacaine 0.2% Injectable Solution ESPB in?
Related
- Manufacturer: Poznan University of Medical Sciences — full pipeline
- Also known as: erector spinae plane block
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing